Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

P&U reports antiasthma agent with a novel mechanism of action

May 8, 1998

Profile of BIIC-1996, a novel dual NK1/NK2 antagonist for respiratory indications

May 8, 1998

Manganic porphyrins for treatment of hyperoxic lung injury

May 8, 1998

CNRS investigators discover CFTR channel activators

May 8, 1998

Antiallergic/antiinflammatory effects of heparin and heparin fractions under evaluation

May 7, 1998

Spotlight on NK antagonists for asthma

May 7, 1998

PDE IV inhibitors focus of attention at recent respiratory care congress

May 7, 1998

Phosphodiesterase inhibitors with antiasthmatic efficacy

May 7, 1998

CytoMed's 5-LO inhibitor shows potential in asthma; clinical trials imminent

May 6, 1998

SB-240563, an anti-IL-5 MAb for the treatment of asthma

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...